Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2006-11-19
pubmed:abstractText
To elucidate the clinical importance of the anti-signal recognition particle (SRP) autoantibody in patients with myositis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-11092199, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-11156543, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-11954871, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-12235311, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-12548521, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-14511932, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-14707323, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-14730618, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-1567494, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-1659647, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-2046947, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-2403400, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-2432596, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-6497519, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-8628498, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-9214426, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-9521271, http://linkedlifedata.com/resource/pubmed/commentcorrection/16679430-9843067
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0003-4967
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1635-8
pubmed:dateRevised
2010-9-15
pubmed:meshHeading
pubmed-meshheading:16679430-Adult, pubmed-meshheading:16679430-Autoantibodies, pubmed-meshheading:16679430-Autoimmune Diseases, pubmed-meshheading:16679430-Biological Markers, pubmed-meshheading:16679430-Biopsy, pubmed-meshheading:16679430-Creatine Kinase, pubmed-meshheading:16679430-Dermatomyositis, pubmed-meshheading:16679430-Female, pubmed-meshheading:16679430-Humans, pubmed-meshheading:16679430-Immunologic Factors, pubmed-meshheading:16679430-Lung Diseases, Interstitial, pubmed-meshheading:16679430-Male, pubmed-meshheading:16679430-Middle Aged, pubmed-meshheading:16679430-Muscle Weakness, pubmed-meshheading:16679430-Muscular Atrophy, pubmed-meshheading:16679430-Polymyositis, pubmed-meshheading:16679430-Prognosis, pubmed-meshheading:16679430-Retrospective Studies, pubmed-meshheading:16679430-Signal Recognition Particle, pubmed-meshheading:16679430-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.
pubmed:affiliation
Department of Neurology, Neuromuscular Centre Nijmegen, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. g.hengstman@neuro.umcn.nl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study